James West

James West

London Mergers & Acquisitions Healthcare +44 20 8126 5130
I strive to build long-term relationships with key individuals in my sectors of focus in order to provide the best advisory services for my clients.

As a member of the firm’s Healthcare Group, James advises mid-market company owners and investors on mergers and acquisitions (M&A). His focus spans the pharmaceutical and pharmaceutical services sectors, advising on both buy-sides and sell-sides. Specifically, he has advised on transactions covering  commercial, manufacturing and research; pharmaceutical products and generics; and medical technology, devices and diagnostics sectors.

Over almost a decade in the industry, James has built up a network and is passionate in helping shape growth strategies for company owners.

Prior to joining Lincoln, James worked at Results International where he led the pharmaceutical services practice. Previously, he worked at KPMG in the healthcare M&A team.

James holds a Master of Pharmacy from Bath University and is a qualified Associate Chartered Accountant.

Perspectives featuring James West

Lincoln’s Latest

In Q3 2020, Lincoln International introduced Lincoln’s Latest video series. Experts from across industries, services and geographies, sharing perspectives on current trends, recent observations and future outlooks through this quarterly… Read More

Global Supply Chain Volatility: 2022 Outlook

Amidst historic production disruption, shortages and low levels of inventory, manufacturers, distributors and retailers have been adapting business strategy real-time in response to continued volatility. There has been a rising… Read More

Q&A with Lincoln Healthcare Director James West: The Future of UK Pharma Services and Manufacturing

Lincoln International recently welcomed James West, a London-based Director in the firm’s global Healthcare Group. With a unique background as a pharmacist turned life sciences investment banker, James joins Lincoln… Read More

Showing 1 – 3 of 3

News & Media featuring James West

Scrip | What Does 2022 Hold For Biopharma?

Originally published by SCRIP on February 8 , 2022. James West, Director in Lincoln’s Healthcare Group shares that there has been increased private equity firm’s interest in the Biopharma space and… Read More

PRWeek | Healthcare M&A in 2022: private equity has ‘huge interest’ in medcomms agencies

Originally published by PRWeek on December 8, 2021. James West, Director in Lincoln’s Healthcare Group discusses private equity firm’s interest in the medcomms space and the forecast for Healthcare M&A activity… Read More

PRWeek | 2021 Will Be Known As Year Medcomms M&A Went Into Overdrive

Originally published by PRWeek on November 10, 2021, by James West. Several large agency groups have taken on fresh private equity capital for the first time this year and many others… Read More

Showing 1 – 3 of 3

Meet our Senior Team in Healthcare